Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.

Riordan NH, Morales I, Fernández G, Allen N, Fearnot NE, Leckrone ME, Markovich DJ, Mansfield D, Avila D, Patel AN, Kesari S, Paz Rodriguez J.

J Transl Med. 2018 Mar 9;16(1):57. doi: 10.1186/s12967-018-1433-7.

2.

Effect of Infla-Kine supplementation on the gene expression of inflammatory markers in peripheral mononuclear cells and on C-reactive protein in blood.

Mikirova NA, Kesari S, Ichim TE, Riordan NH.

J Transl Med. 2017 Oct 20;15(1):213. doi: 10.1186/s12967-017-1315-4.

3.

Safety of targeting tumor endothelial cell antigens.

Wagner SC, Riordan NH, Ichim TE, Szymanski J, Ma H, Perez JA, Lopez J, Plata-Munoz JJ, Silva F, Patel AN, Kesari S.

J Transl Med. 2016 Apr 12;14:90. doi: 10.1186/s12967-016-0842-8. Review.

4.

Case report of non-healing surgical wound treated with dehydrated human amniotic membrane.

Riordan NH, George BA, Chandler TB, McKenna RW.

J Transl Med. 2015 Jul 24;13:242. doi: 10.1186/s12967-015-0608-8.

5.

Scalable efficient expansion of mesenchymal stem cells in xeno free media using commercially available reagents.

Riordan NH, Madrigal M, Reneau J, de Cupeiro K, Jiménez N, Ruiz S, Sanchez N, Ichim TE, Silva F, Patel AN.

J Transl Med. 2015 Jul 17;13:232. doi: 10.1186/s12967-015-0561-6.

6.

A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods.

Madrigal M, Rao KS, Riordan NH.

J Transl Med. 2014 Oct 11;12:260. doi: 10.1186/s12967-014-0260-8. Review.

7.

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.

Wagner SC, Markosian B, Ajili N, Dolan BR, Kim AJ, Alexandrescu DT, Dasanu CA, Minev B, Koropatnick J, Marincola FM, Riordan NH.

J Transl Med. 2014 May 13;12:127. doi: 10.1186/1479-5876-12-127. Review.

8.

The bio-energetic theory of carcinogenesis.

Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T, Quintero-Del-Rio AI, Ortiz N.

Med Hypotheses. 2012 Oct;79(4):433-9. doi: 10.1016/j.mehy.2012.06.015. Epub 2012 Jul 17.

PMID:
22809841
9.

Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.

Rodriguez JP, Murphy MP, Hong S, Madrigal M, March KL, Minev B, Harman RJ, Chen CS, Timmons RB, Marleau AM, Riordan NH.

Int Arch Med. 2012 Feb 8;5:5. doi: 10.1186/1755-7682-5-5.

10.

Schedule Dependence in Cancer Therapy: Intravenous Vitamin C and the Systemic Saturation Hypothesis.

Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T.

J Orthomol Med. 2012 Jan 1;27(1):9-12.

11.

The king is dead, long live the king: entering a new era of stem cell research and clinical development.

Ichim T, Riordan NH, Stroncek DF.

J Transl Med. 2011 Dec 20;9:218. doi: 10.1186/1479-5876-9-218.

12.

IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?

Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Dasanu CA.

J Immunother. 2011 Oct;34(8):607-609. No abstract available.

13.

Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?

Mansilla E, Díaz Aquino V, Zambón D, Marin GH, Mártire K, Roque G, Ichim T, Riordan NH, Patel A, Sturla F, Larsen G, Spretz R, Núñez L, Soratti C, Ibar R, van Leeuwen M, Tau JM, Drago H, Maceira A.

Stem Cells Int. 2011;2011:943216. doi: 10.4061/2011/943216. Epub 2011 Jun 13.

14.

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda-Massari JR, Alexandrescu DT, Dasanu CA, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH.

J Transl Med. 2011 Mar 4;9:25. doi: 10.1186/1479-5876-9-25.

15.

On the missing link between inflammation and cancer.

Alexandrescu DT, Riordan NH, Ichim TE, Kauffman CL, Kabigting F, Dutton CT, Dasanu CA.

Dermatol Online J. 2011 Jan 15;17(1):10. Review.

16.

Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia.

Alexandrescu DT, Kauffman CL, Ichim TE, Riordan NH, Kabigting F, Dasanu CA.

Dermatol Online J. 2011 Jan 15;17(1):2. Review.

17.

Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report.

Ichim TE, Solano F, Lara F, Paris E, Ugalde F, Rodriguez JP, Minev B, Bogin V, Ramos F, Woods EJ, Murphy MP, Patel AN, Harman RJ, Riordan NH.

Int Arch Med. 2010 Nov 11;3:30. doi: 10.1186/1755-7682-3-30.

18.

Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factors.

Mikirova NA, Belcaro G, Jackson JA, Riordan NH.

Panminerva Med. 2010 Jun;52(2 Suppl 1):81-7.

PMID:
20657540
19.

Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?

Ichim TE, Zhong Z, Mikirova NA, Jackson JA, Hunninghake R, Mansilla E, Marín G, Núñez L, Patel AN, Angle N, Murphy MP, Dasanu CA, Alexandrescu DT, Bogin V, Riordan NH.

Panminerva Med. 2010 Jun;52(2 Suppl 1):75-80. Review.

PMID:
20657539
20.

Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions.

Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, Hu X.

J Transl Med. 2010 Aug 3;8:75. doi: 10.1186/1479-5876-8-75.

Supplemental Content

Loading ...
Support Center